Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 Next >>

Date	Time	Source	Headline	Symbol	Company
03/25/2022	2:55PM	Edgar (US Regulatory)	Notice of Exempt Solicitation. Definitive Material. (px14a6g)	NYSE:ABBV	AbbVie Inc
03/21/2022	5:02PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NYSE:ABBV	AbbVie Inc
03/21/2022	5:01PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NYSE:ABBV	AbbVie Inc
03/21/2022	8:30AM	PR Newswire (US)	AbbVie and Allergan Aesthetics to Present New Research Across Dermatology Portfolio at 2022 AAD Annual Meeting	NYSE:ABBV	AbbVie Inc
03/20/2022	5:41AM	TipRanks	Weekly Market Review: Higher Interest Rates Met With Historic Rebound	NYSE:ABBV	AbbVie Inc
03/17/2022	3:05PM	TipRanks	BMO Capital Reaffirms Their Buy Rating on AbbVie (ABBV)	NYSE:ABBV	AbbVie Inc
03/17/2022	1:02PM	Dow Jones News	AbbVie's Psoriatic Arthritis Treatment SKYRIZI Approved by Health Canada	NYSE:ABBV	AbbVie Inc
03/17/2022	12:31PM	PR Newswire (Canada)	AbbVie élargit sa gamme de produits en immunologie au Canada alors que Santé Canada homologue SKYRIZI® (risankizumab) pour le traitement des adultes atteints de rhumatisme psoriasique évolutif	NYSE:ABBV	AbbVie Inc
03/17/2022	12:14PM	PR Newswire (Canada)	AbbVie Expands Immunology Portfolio in Canada as Health Canada approves SKYRIZI® (risankizumab) for the Treatment of Adults with Active Psoriatic Arthritis	NYSE:ABBV	AbbVie Inc
03/16/2022	5:29PM	PR Newswire (US)	RINVOQ® (upadacitinib) Receives FDA Approval for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis	NYSE:ABBV	AbbVie Inc
03/16/2022	10:19AM	TipRanks	Drugmakers to Continue Medical Supplies in Russia, Halt Other Businesses	NYSE:ABBV	AbbVie Inc
03/15/2022	8:50AM	Dow Jones News	AbbVie, Scripps Research to Collaborate on New Covid Treatments	NYSE:ABBV	AbbVie Inc
03/15/2022	8:45AM	PR Newswire (US)	Now Available Over the Counter, LASTACAFT® Provides Eye Allergy Itch Relief in Minutes that Lasts Through 16 Hours	NYSE:ABBV	AbbVie Inc
03/15/2022	8:00AM	PR Newswire (US)	AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19	NYSE:ABBV	AbbVie Inc
03/14/2022	3:18AM	TipRanks	AbbVie, Gedeon Richter Join Hands for Potential Treatment Neuropsychiatric Diseases	NYSE:ABBV	AbbVie Inc
03/11/2022	10:16AM	TipRanks	AbbVie Stock: Strong Partnerships Bode Well	NYSE:ABBV	AbbVie Inc
03/11/2022	9:18AM	TipRanks	BMO Capital Believes AbbVie (ABBV) Still Has Room to Grow	NYSE:ABBV	AbbVie Inc
03/11/2022	2:00AM	PR Newswire (US)	AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases	NYSE:ABBV	AbbVie Inc
03/10/2022	12:35PM	TipRanks	Mizuho Securities Believes AbbVie (ABBV) Won’t Stop Here	NYSE:ABBV	AbbVie Inc
03/10/2022	9:08AM	Dow Jones News	AbbVie's Qulipta Hits Main Endpoints in Chronic Migraine	NYSE:ABBV	AbbVie Inc
03/10/2022	8:15AM	PR Newswire (US)	AbbVie Announces Positive Phase 3 Atogepant (QULIPTA™) Data for the Preventive Treatment of Chronic Migraine	NYSE:ABBV	AbbVie Inc
03/09/2022	5:06AM	TipRanks	Genmab & AbbVie Obtain Orphan Drug Designation for Epcoritamab in the U.S.	NYSE:ABBV	AbbVie Inc
03/08/2022	5:26PM	Dow Jones News	AbbVie Resolves Humira Litigation with Alvotech	NYSE:ABBV	AbbVie Inc
03/08/2022	4:32PM	PR Newswire (US)	AbbVie Resolves HUMIRA® (adalimumab) U.S. Litigation with Alvotech	NYSE:ABBV	AbbVie Inc
03/08/2022	8:18AM	Dow Jones News	Genmab Gets FDA Orphan Designation to Epcoritamab in Follicular Lymphoma	NYSE:ABBV	AbbVie Inc
03/08/2022	7:30AM	Business Wire	Genmab Announces U.S. Food and Drug Administration Granted Orphan-Drug Designation to Epcoritamab (DuoBody®-CD3xCD20) in Follicular Lymphoma	NYSE:ABBV	AbbVie Inc
03/07/2022	5:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
03/04/2022	4:17PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
03/02/2022	5:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
03/02/2022	2:48PM	Benzinga	36 Stocks To Watch After Biden's First State of The Union Address	NYSE:ABBV	AbbVie Inc